Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin

Clinica Chimica Acta

Volumn 411, Issue 3-4, 2010, Pages 155-160

  McCudden, Christopher R ^a   Sharpless, Julie L ^a   Grenache, David G ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Immunoassay; Macroprolactin; Prolactin; Sensitivity and specificity

Indexed keywords

MACROGOL; MACROPROLACTIN; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FRACTIONATION; GALACTORRHEA; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERPROLACTINEMIA; IMMUNOASSAY; IMMUNODETECTION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SYMPTOM;

ADOLESCENT; ADULT; AGED; CHEMICAL PRECIPITATION; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNOASSAY; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROLACTIN; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 72449158657     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.10.020     Document Type: Article

References (24)

1. Melmed S., Kleinberg D., Larsen P.R., Kronenberg H.M., Melmed S., and Polonsky K.S. Anterior pituitary. Williams Textbook of Endocrinology (2003), Saunders, Philadelphia 177-279
2. Hattori N., and Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J Clin Endocrinol Metab 82 (1997) 3107-3110
3. Olukoga A.O., and Kane J.W. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 51 (1999) 119-126
4. Vallette-Kasic S., Morange-Ramos I., Selim A., et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Enocrinol Metab 87 (2002) 581-588
5. Alfonso A., Rieniets K.I., and Vigersky R.A. Incidence and clinical significance of elevated macroprolactin levels in patients with hyperprolactinemia. Endocr Pract 12 (2006) 275-280
6. Gibney J., Smith T.P., and McKenna T.J. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90 (2005) 3927-3932
7. Smith T.P., Kavanagh L., Healy M.L., and McKenna T.J. Technology insight: measuring prolactin in clinical samples. Nature Clin Pract 3 (2007) 279-289
8. Suliman A.M., Smith T.P., Gibney J., and McKenna T.J. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49 (2003) 1504-1509
9. Aron D.C., and Howlett T.A. Pituitary incidentalomas. Edocrinol Metab Clin N Am 29 (2000) 205-221
10. Fahie-Wilson M.N., and Soule S.G. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34 (1997) 252-258
11. Hauache O.M., Rocha A.J., Maia A.C., Maciel R.M., and Vieira J.G. Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol 57 (2002) 327-331
12. Ellis M.J., Reed M.R., and Livesey J.H. Cross-reactivities of macroprolactin and big-prolactin in three commercial immunoassays for prolactin: a chromatographic analysis. Clin Biochem 40 (2007) 1285-1290
13. Fahie-Wilson M., Bieglmayer C., Kratzsch J., et al. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. Clin Lab 53 (2007) 485-492
14. Smith T.P., Suliman A.M., Fahie-Wilson M.N., and McKenna T.J. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87 (2002) 5410-5415
15. Fahie-Wilson M.N. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem 46 (2000) 2022-2023
16. Fahie-Wilson M.N. Polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 45 (1999) 436-437
17. Vieira J.G., Tachibana T.T., Obara L.H., and Maciel R.M. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 44 (1998) 1758-1759
18. Leslie H., Courtney C.H., Bell P.M., et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86 (2001) 2743-2746
19. Fahie-Wilson M.N., John R., and Ellis A.R. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 42 (2005) 175-192
20. Pathologists CoA, Participant Summary Survey Y-B Ligand (Special). 2008.
21. Kavanagh L., McKenna T.J., Fahie-Wilson M.N., Gibney J., and Smith T.P. Specificity and clinical utility of methods for the detection of macroprolactin. Clin Chem 52 (2006) 1366-1372
22. Beltran L., Fahie-Wilson M.N., McKenna T.J., Kavanagh L., and Smith T.P. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem 54 (2008) 1673-1681
23. Casanueva F.F., Molitch M.E., Schlechte J.A., et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65 (2006) 265-273
24. Donadio F., Barbieri A., Angioni R., et al. Patients with macroprolactinaemia: clinical and radiological features. Eur J Clin Investig 37 (2007) 552-557